The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vamsi Krishna Potluri & PACs
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter Vamsi Krishna Potluri, along with Persons Acting in Concert (PACs), has disclosed the acquisition of 50 lakh equity shares (5.64% of total share capital) of SMS Pharmaceuticals on September 10, 2025. The shares were acquired through conversion of 50 lakh warrants into equity shares via preferential allotment, with Vamsi Krishna Potluri receiving 25 lakh shares and Trilok Potluri receiving 25 lakh shares. Post-acquisition, the promoter group's voting rights (excluding encumbered shares) increased from 41.35% to 46.99%, while total promoter holding including encumbrance remains at 71.90%. The company's total share capital expanded from 8.87 crore to 9.37 crore equity shares of Re 1 each.
This conversion strengthens promoter group's effective control and signals their continued commitment to the company. Since the warrant conversion was a pre-agreed preferential allotment, the disclosure is largely procedural and unlikely to cause major stock price movement, but it confirms promoter confidence and removes dilution overhang.